Free Trial

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$41.29 -0.90 (-2.12%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$40.34 -0.95 (-2.30%)
As of 06/5/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. LIVN, IRTC, NVST, MMED, and SLNO

Should you buy Inspire Medical Systems stock or one of its competitors? MarketBeat compares Inspire Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspire Medical Systems include LivaNova (LIVN), iRhythm Technologies (IRTC), Envista (NVST), MiniMed Group (MMED), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

How does Inspire Medical Systems compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

97.6% of LivaNova shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 0.4% of LivaNova shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, LivaNova had 2 more articles in the media than Inspire Medical Systems. MarketBeat recorded 3 mentions for LivaNova and 1 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 0.10 beat LivaNova's score of 0.09 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspire Medical Systems has lower revenue, but higher earnings than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.39B2.86-$242.47M$1.9537.11
Inspire Medical Systems$911.98M1.30$145.42M$4.499.20

Inspire Medical Systems has a net margin of 14.33% compared to LivaNova's net margin of 7.48%. LivaNova's return on equity of 16.48% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova7.48% 16.48% 7.59%
Inspire Medical Systems 14.33%10.35%8.81%

LivaNova has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

LivaNova currently has a consensus price target of $79.38, suggesting a potential upside of 9.69%. Inspire Medical Systems has a consensus price target of $81.84, suggesting a potential upside of 98.19%. Given Inspire Medical Systems' higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

Summary

LivaNova beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to iRhythm Technologies?

Inspire Medical Systems (NYSE:INSP) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Inspire Medical Systems has a net margin of 14.33% compared to iRhythm Technologies' net margin of -3.53%. Inspire Medical Systems' return on equity of 10.35% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
iRhythm Technologies -3.53%-10.26%-1.39%

Inspire Medical Systems presently has a consensus target price of $81.84, suggesting a potential upside of 98.19%. iRhythm Technologies has a consensus target price of $189.69, suggesting a potential upside of 75.46%. Given Inspire Medical Systems' higher possible upside, equities research analysts clearly believe Inspire Medical Systems is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

94.9% of Inspire Medical Systems shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Inspire Medical Systems has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

Inspire Medical Systems has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.30$145.42M$4.499.20
iRhythm Technologies$747.14M4.75-$44.55M-$0.86N/A

In the previous week, iRhythm Technologies had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 4 mentions for iRhythm Technologies and 1 mentions for Inspire Medical Systems. iRhythm Technologies' average media sentiment score of 0.89 beat Inspire Medical Systems' score of 0.10 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
iRhythm Technologies
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inspire Medical Systems beats iRhythm Technologies on 10 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to Envista?

Envista (NYSE:NVST) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

Inspire Medical Systems has a net margin of 14.33% compared to Envista's net margin of 2.41%. Inspire Medical Systems' return on equity of 10.35% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Inspire Medical Systems 14.33%10.35%8.81%

Inspire Medical Systems has lower revenue, but higher earnings than Envista. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.38$47M$0.4156.29
Inspire Medical Systems$911.98M1.30$145.42M$4.499.20

Envista has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

94.9% of Inspire Medical Systems shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Inspire Medical Systems had 1 more articles in the media than Envista. MarketBeat recorded 1 mentions for Inspire Medical Systems and 0 mentions for Envista. Envista's average media sentiment score of 0.50 beat Inspire Medical Systems' score of 0.10 indicating that Envista is being referred to more favorably in the media.

Company Overall Sentiment
Envista Positive
Inspire Medical Systems Neutral

Envista currently has a consensus price target of $28.83, suggesting a potential upside of 24.94%. Inspire Medical Systems has a consensus price target of $81.84, suggesting a potential upside of 98.19%. Given Inspire Medical Systems' higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.40
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

Summary

Inspire Medical Systems beats Envista on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Inspire Medical Systems (NYSE:INSP) are both medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

19.7% of MiniMed Group shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.2% of MiniMed Group shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Inspire Medical Systems has lower revenue, but higher earnings than MiniMed Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$2.99B1.34N/AN/AN/A
Inspire Medical Systems$911.98M1.30$145.42M$4.499.20

Inspire Medical Systems has a net margin of 14.33% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 10.35% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Inspire Medical Systems 14.33%10.35%8.81%

MiniMed Group currently has a consensus target price of $21.33, suggesting a potential upside of 49.92%. Inspire Medical Systems has a consensus target price of $81.84, suggesting a potential upside of 98.19%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than MiniMed Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.73
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

In the previous week, MiniMed Group had 8 more articles in the media than Inspire Medical Systems. MarketBeat recorded 9 mentions for MiniMed Group and 1 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 0.10 beat MiniMed Group's score of -0.21 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiniMed Group
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspire Medical Systems beats MiniMed Group on 7 of the 12 factors compared between the two stocks.

How does Inspire Medical Systems compare to Soleno Therapeutics?

Inspire Medical Systems (NYSE:INSP) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Soleno Therapeutics has a net margin of 33.70% compared to Inspire Medical Systems' net margin of 14.33%. Soleno Therapeutics' return on equity of 22.85% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
Soleno Therapeutics 33.70%22.85%18.25%

In the previous week, Inspire Medical Systems had 1 more articles in the media than Soleno Therapeutics. MarketBeat recorded 1 mentions for Inspire Medical Systems and 0 mentions for Soleno Therapeutics. Soleno Therapeutics' average media sentiment score of 0.94 beat Inspire Medical Systems' score of 0.10 indicating that Soleno Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Inspire Medical Systems Neutral
Soleno Therapeutics Positive

Inspire Medical Systems presently has a consensus price target of $81.84, indicating a potential upside of 98.19%. Soleno Therapeutics has a consensus price target of $76.67, indicating a potential upside of 44.63%. Given Inspire Medical Systems' higher probable upside, research analysts clearly believe Inspire Medical Systems is more favorable than Soleno Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05
Soleno Therapeutics
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

Inspire Medical Systems has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Soleno Therapeutics has a beta of -2.22, suggesting that its stock price is 322% less volatile than the broader market.

Inspire Medical Systems has higher revenue and earnings than Soleno Therapeutics. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.30$145.42M$4.499.20
Soleno Therapeutics$285.01M9.69$20.89M$1.7729.95

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 6.4% of Soleno Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Soleno Therapeutics beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$1.19B$1.53B$6.68B$23.06B
Dividend YieldN/AN/A2.67%4.10%
P/E Ratio9.2078.1924.0630.25
Price / Sales1.307.19516.1722.11
Price / Cash14.3822.8942.2323.97
Price / Book1.544.779.734.63
Net Income$145.42M-$54.76M$3.57B$1.07B
7 Day Performance-0.40%-2.69%-1.28%-1.66%
1 Month Performance-9.21%3.91%1.38%-1.07%
1 Year Performance-69.58%-5.16%23.93%21.20%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
4.0242 of 5 stars
$41.29
-2.1%
$81.84
+98.2%
-69.6%$1.19B$911.98M9.201,333
LIVN
LivaNova
2.7073 of 5 stars
$73.83
flat
$79.38
+7.5%
+57.5%$4.06B$1.39B37.863,300
IRTC
iRhythm Technologies
4.24 of 5 stars
$116.56
flat
$191.85
+64.6%
-26.3%$3.83B$747.14MN/A2,400
NVST
Envista
3.0579 of 5 stars
$23.41
-0.1%
$28.83
+23.2%
+22.9%$3.81B$2.72B57.0912,000
MMED
MiniMed Group
3.4349 of 5 stars
$11.87
flat
$21.67
+82.5%
N/A$3.33B$2.99BN/A8,000

Related Companies and Tools


This page (NYSE:INSP) was last updated on 6/7/2026 by MarketBeat.com Staff.
From Our Partners